Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.

Abstract

Maple syrup urine disease (MSUD) is a rare metabolic disorder for which the newborn screening (NBS) is possible but it has not been yet implemented for most Spanish regions. In the present study, we assess the clinical features and outcome of 14 MSUD Spanish patients with similar treatment protocol diagnosed either by NBS or by clinical symptoms. Eight patients were detected by NBS, four classic and four moderate MSUD. The average age at detection was 4.6 days, the mean plasmatic concentration of leucine at diagnosis was 1807 μM; the average number of days with leucine >1000 μM was 0.7 (0-4) and the mean number of total hospitalizations was 1.6 (0-5). Mean follow-up time was 70 months. They had good evolution: all remain asymptomatic, but 2 patients have attention deficit and hyperactivity disorder. Six patients with late diagnosis of classic MSUD were followed during 41 months. All presented with acute encephalopathy during the first month of life, mean leucine levels of 2355 μM, mean number of days with leucine >1000 μM of 6.6 (1-13) and mean number of total hospitalizations of 5.3 (4-7). Only two patients have a psychomotor development index in the lower limit (80 and 83). For all patients a good genotype-phenotype correlation was found and four novel mutations were identified: p.A311H, p.T84S, p.T397L, pL398P. Our study support that NBS improves prognosis of MSUD patients. But early diagnosis and an aggressive treatment together with a close monitoring of leucine levels improve neurological evolution in MSUD patients, even for those not detected by NBS.

DOI: 10.1016/j.ejpn.2015.07.009

Statistics

02004006002017
Citations per Year

140 Citations

Semantic Scholar estimates that this publication has 140 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Couce2015EvolutionOM, title={Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.}, author={Mar{\'i}a Luz Couce and Feliciano J. Ramos and Maria Amor Bueno and J D{\'i}az and Silvia Meavilla and Maria Dolores Boveda and Ana Fern{\'a}ndez-Marmiesse and {\'A}ngels Garc{\'i}a-Cazorla}, journal={European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society}, year={2015}, volume={19 6}, pages={652-9} }